title: Maternal undernutrition programmes atherosclerosis in the ApoE*3-Leiden mouse.
abstract: Poor quality of nutrition during fetal development is associated with adverse health outcomes in adult life. Epidemiological studies suggest that markers of fetal undernutrition are predictive of risk of the metabolic syndrome and CHD. Here we show that feeding a low-protein diet during pregnancy programmed the development of atherosclerosis in ApoE*3-Leiden mice. ApoE*3-Leiden mice carry a mutation of human ApoE*3 rendering them prone to atherosclerosis when fed a diet rich in cholesterol. It was noted that fetal exposure to protein restriction led to a greater degree of dyslipidaemia in mice when fed an atherogenic diet, with low-protein-exposed ApoE*3 mice having elevated total plasma cholesterol (34 % higher; P < 0.001) and TAG (39 % higher; P < 0.001) relative to offspring exposed to a control diet in utero. The low-protein group developed more severe atherosclerotic lesions within the aortic arch (2.61-fold greater lesion area; P < 0.001). Analysis of a targeted gene array suggested a potential role for members of the LDL receptor superfamily, along with similar programmed suppression of the mRNA expression of hepatic sterol regulatory element-binding protein-1c. This indicates that disordered lipid metabolism may play a role in the fetal programming of atherosclerosis in this model. Whereas earlier studies have shown early programming of cardiovascular risk factors, these results demonstrate for the first time that the interaction of prenatal undernutrition with a postnatal atherogenic diet increases the extent of atherosclerotic disease.
authors.affiliation: School of Biosciences, University of Nottingham, Sutton Bonington, Loughborough LE12 5RD, UK.
authors.forename: Zoe
authors.initials: Z
authors.lastname: Yates
authors.forename: Elizabeth J
authors.initials: EJ
authors.lastname: Tarling
authors.forename: Simon C
authors.initials: SC
authors.lastname: Langley-Evans
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Salter
mesh_terms: D000818:Animals; D053318:Apolipoprotein E3 / Q000235:genetics; D050197:Atherosclerosis / Q000196:embryology* / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D018753:Diet, Protein-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage; D005260:Female; D047109:Fetal Development / Q000502:physiology; D005838:Genotype; D050356:Lipid Metabolism / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000503:physiopathology*; D039401:Prenatal Nutritional Physiological Phenomena; D014280:Triglycerides / Q000097:blood
chemical_list: D053318:Apolipoprotein E3; D004044:Dietary Proteins; D014280:Triglycerides; D002784:Cholesterol
references.citation: Physiol Rev. 2006 Apr;86(2):465-514
references.pmid: 16601267
references.citation: Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
references.pmid: 12184808
references.citation: Lancet. 1989 Sep 9;2(8663):577-80
references.pmid: 2570282
references.citation: J Clin Invest. 1997 Dec 1;100(11):2680-90
references.pmid: 9389731
references.citation: Eur Heart J. 2001 Jan;22(1):4-9
references.pmid: 11133201
references.citation: Cell. 1997 May 2;89(3):331-40
references.pmid: 9150132
references.citation: Proc Nutr Soc. 2006 Feb;65(1):97-105
references.pmid: 16441949
references.citation: J Clin Invest. 1998 Feb 1;101(3):689-95
references.pmid: 9449704
references.citation: Circ Res. 2000 Nov 10;87(10):946-52
references.pmid: 11073892
references.citation: Br J Nutr. 2007 Sep;98(3):517-24
references.pmid: 17442129
references.citation: Science. 2004 Sep 17;305(5691):1733-6
references.pmid: 15375258
references.citation: J Clin Invest. 1998 Jun 1;101(11):2331-9
references.pmid: 9616204
references.citation: J Clin Invest. 1991 Aug;88(2):643-55
references.pmid: 1864973
references.citation: Clin Nutr. 1994 Oct;13(5):319-24
references.pmid: 16843406
references.citation: Lancet. 1993 Apr 10;341(8850):938-41
references.pmid: 8096277
references.citation: Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1702-14
references.pmid: 17299084
references.citation: Circulation. 2002 Mar 19;105(11):1360-7
references.pmid: 11901049
references.citation: Clin Sci (Lond). 1994 Feb;86(2):217-22; discussion 121
references.pmid: 8143432
references.citation: Atherosclerosis. 1987 Dec;68(3):231-40
references.pmid: 3426656
references.citation: Hum Mutat. 1992;1(6):445-66
references.pmid: 1301956
references.citation: J Biol Chem. 1993 May 15;268(14):10540-5
references.pmid: 7683682
references.citation: Int J Obes Relat Metab Disord. 2001 May;25(5):735-40
references.pmid: 11360158
references.citation: J Clin Invest. 1996 Mar 1;97(5):1184-92
references.pmid: 8636429
references.citation: Clin Chem Lab Med. 2005;43(5):470-9
references.pmid: 15899668
references.citation: Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):926-33
references.pmid: 8696955
references.citation: ILAR J. 2006;47(1):5-14
references.pmid: 16391426
references.citation: Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11603-7
references.pmid: 7903453
references.citation: Clin Sci (Lond). 1996 Nov;91(5):607-15
references.pmid: 8942400